# K062834: Osteon, Models GBG0305, GBG0510, GBG1020, GBG2030, GBG3040, GBG4050

- Pathway: 510(k) (Abbreviated)
- Applicant: Genoss Co., Ltd.
- Decided: Apr 24, 2007 after 215 days
- Product code: LYC (Bone Grafting Material, Synthetic)
- Device class: 2
- Regulation: 21 CFR 872.3930
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K990131 (1999). 6 ancestors in all.
5 later devices descend from it; 3 cite it directly.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K051885: MBCP, Biomatlante (2005) Summary page 1.

## Most influential descendants
- K112716: Osteon II (2012), 1 descendant of its own
- K081784: Mastergraft Putty (2008), 1 descendant of its own
- K251818: Bontree Plus (2026), 0 descendants of its own
- K140374: Mastergraft Putty (2014), 0 descendants of its own
- K102015: Osteon, Osteon Sinus, Osteon Lifting (2010), 0 descendants of its own

## Indications for use
OSTEON is intended for use as a bone grafting material to fill, augment or reconstruct periodontal or oral/maxillofacial defects. - Periodontal/Infrabony defects - Ridge augmentation - Extraction sites (implant preparation/placement) - Sinus lifts - Cystic cavities

Source page: https://510kreport.com/device/K062834
Methodology: https://510kreport.com/methodology